Company Filing History:
2 out of 49 
1 out of 27,320 
1 out of 832,891 Years Active: 2016-2023
Title: Cheng Cheng: Innovator in Polypeptide Technology
Introduction
Cheng Cheng is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and their applications in medicine. With a total of 3 patents to his name, Cheng's work is paving the way for advancements in therapeutic methods and diagnostic tools.
Latest Patents
Cheng Cheng's latest patents focus on a polypeptide and its various uses. These patents include a polypeptide and nucleic acid for encoding the polypeptide, a nucleic-acid construct, an expression vector, and a host cell containing the nucleic acid. His innovations also encompass an antigen-presenting cell that presents the polypeptide on its surface, along with immune effector cells. Furthermore, he has developed a pharmaceutical composition containing the polypeptide, as well as a vaccine that incorporates the nucleic acid, nucleic acid construct, expression vector, host cell, antigen-presenting cell, and immune effector cell. Cheng's patents also detail a therapeutic method utilizing the polypeptide, nucleic acid, pharmaceutical composition, vaccine, and antibody. Additionally, he has provided a diagnosis method and apparatus for detecting the described polypeptide, along with applications for preparing vaccines, tumor diagnosis kits, and pharmaceutical compositions.
Career Highlights
Cheng Cheng has worked with notable companies such as BGI Shenzhen and Huawei Technologies Co., Limited. His experience in these organizations has contributed to his expertise in biotechnology and innovation.
Collaborations
Cheng has collaborated with talented individuals in his field, including Yunxia Tang and Bo Li. Their joint efforts have further enhanced the impact of his work in biotechnology.
Conclusion
Cheng Cheng is a distinguished inventor whose work in polypeptide technology is making significant strides in medical applications. His patents and collaborations reflect his commitment to advancing the field of biotechnology.